Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional non-small-cell lung cancer.
Sculier JP, Lafitte JJ, Berghmans T, Van Houtte P, Lecomte J, Thiriaux J, Efremidis A, Koumakis G, Giner V, Richez M, Corhay JL, Wackenier P, Lothaire P, Paesmans M, Mommen P, Ninane V; European Lung Cancer Working Party. Sculier JP, et al. Among authors: thiriaux j. Ann Oncol. 2004 Mar;15(3):399-409. doi: 10.1093/annonc/mdh105. Ann Oncol. 2004. PMID: 14998841 Free article. Clinical Trial.
A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer. EORTC Lung Cancer Working Party.
Sculier JP, Klastersky J, Libert P, Ravez P, Thiriaux J, Lecomte J, Bureau G, Vandermoten G, Dabouis G, Michel J, et al. Sculier JP, et al. Among authors: thiriaux j. Ann Oncol. 1990;1(2):128-33. doi: 10.1093/oxfordjournals.annonc.a057690. Ann Oncol. 1990. PMID: 1964073 Free article. Clinical Trial.
A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.
Klastersky J, Sculier JP, Lacroix H, Dabouis G, Bureau G, Libert P, Richez M, Ravez P, Vandermoten G, Thiriaux J, et al. Klastersky J, et al. Among authors: thiriaux j. J Clin Oncol. 1990 Sep;8(9):1556-62. doi: 10.1200/JCO.1990.8.9.1556. J Clin Oncol. 1990. PMID: 2167953 Clinical Trial.
Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.
Paesmans M, Sculier JP, Libert P, Bureau G, Dabouis G, Thiriaux J, Michel J, Van Cutsem O, Sergysels R, Mommen P, et al. Paesmans M, et al. Among authors: thiriaux j. J Clin Oncol. 1995 May;13(5):1221-30. doi: 10.1200/JCO.1995.13.5.1221. J Clin Oncol. 1995. PMID: 7738625 Clinical Trial.
Phase II randomized trial comparing high-dose cisplatin with moderate-dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.
Sculier JP, Klastersky J, Giner V, Bureau G, Thiriaux J, Dabouis G, Efremidis A, Ries F, Berchier MC, Sergysels R, et al. Sculier JP, et al. Among authors: thiriaux j. J Clin Oncol. 1994 Feb;12(2):353-9. doi: 10.1200/JCO.1994.12.2.353. J Clin Oncol. 1994. PMID: 8113843 Clinical Trial.
64 results